Contents

Search


hepatitis D virus (delta agent, HDV)

RNA virus. Only infects patients with concurrent hepatitis B virus (HBV) infection. Epidemiology: 1) incidence highest with repeated percutaneous exposures a) injection drug users b) hemophilia 2) when HDV infection occurs simultaneously with HBV infection, both infections tend to be self-limited 3) when HDV superinfects established HBV infection, more severe clinical hepatitis & chronic HDV infection occurs Pathology: 1) HDV suppresses HBV replication 2) requires HBsAg to become an infectious virus 3) HDAg may interfere with RNA production & produce cell damage Clinical manifestations: 1) more severe acute hepatitis than with HBV alone 2) increased risk of fulminant hepatitis 3) more chronic hepatitis with increased risk of cirrhosis (70-80%) than with HBV alone Laboratory: 1) hepatitis D serology 2) hepatitis D antigen (HDAg) indicates active infection - hepatitis D antigen in serum - hepatitis D antigen in urine - immunohistochemical staining of liver tissue 4) serum HBeAg is negative (HBV replication is suppressed) 5) Hepatitis D virus RNA 6) see ARUP consult [3] Management: 1) prevention: elimination of high-risk behavior 2) interferon alpha results in temporary reduction of HDV levels with relapse upon discontinuation of therapy

Related

hepatitis D virus RNA hepatitis virus viral hepatitis

General

defective virus

Properties

KINGDOM: virus

References

  1. Medical Knowledge Self Assessment Program (MKSAP) 11, 14. American College of Physicians, Philadelphia 1998, 2006.
  2. Clinical Guide to Laboratory Tests, 3rd ed. Teitz ed., W.B. Saunders, 1995
  3. ARUP Consult: Hepatitis Delta Virus - HDV The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/hepatitis-delta-virus